Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

EMIT HypothermX HX100 wins FDA nod

EMIT, a developer, manufacturer of products for the treatment and prevention of hypothermia, has received the US Food and Drug Administration 510(k) approval to market HypothermX HX100 device.

The HypothermX HX100 device is a patent protected portable fluid warming device designed to warm intravenous fluids, blood or blood products infused into a patient to prevent or treat trauma, environmental, procedure related or induced hypothermia.

EMIT founder, chairman and CEO Sheldon said HypothermX HX100 is a light weight (< 3.0 lbs), portable, long-term (>4 hours continuous use) solution which offers actual therapeutic warming in the field for injured patients.

"HypothermX HX100 is capable of warming up to 5 liters of saline introduced at 15 degrees C and 15 units of packed red blood cells introduced at 5 degrees C to 38 degrees C +/- 3 degrees C with an infusion rate between 50 ml/min and 200 ml/min and ambient conditions between 0 degrees C and 40 degrees C," Sheldon said.

"Our market clearance represents a milestone for the company and we will begin an sales and marketing campaign in the military and civilian market sectors this quarter."